期刊文献+

涎腺腺样囊性癌SACC-83细胞C-erbB2、PTEN基因表达的研究 被引量:1

C-erbB2 and PTEN expressions in salivary gland adenoid cystic carcinoma cell line SACC-83
暂未订购
导出
摘要 目的检测涎腺腺样囊性癌SACC-83细胞中C-erbB2基因和PTEN基因的表达,并探讨其相关性。方法培养SACC-83细胞,采用RT-PCR、免疫组化技术分别检测C-erbB2基因和PTEN基因的mRNA、蛋白产物在涎腺腺样囊性癌SACC-83细胞和正常腺体细胞中的表达情况。结果 C-erbB2基因mRNA及蛋白水平在SACC-83细胞中的表达明显高于正常腺体细胞,差异有显著性;PTEN基因在SACC-83细胞及正常腺体细胞中的表达无明显差异。结论 C-erbB2基因在涎腺腺样囊性癌SACC-83细胞中过表达,可能与涎腺腺样囊性癌的发生有关。 Objective To detect the expressions of C-erbB2 and PTEN in salivary gland adenoid cystic carcinoma cell line SACC-83,and study the correlation of them.Methods After we cultured SACC-83 cell,RT-PCR and immunohistochemistry were employed to detect the expressions of C-erbB2 and PTEN in SACC-83 cell and normal salivary gland cell.Results The expression of C-erbB2 in SACC-83 cell was conspicuously higher than that in normal salivary gland cell.But the expressions of PTEN in SACC-83 cell and normal salivary gland cell were not different.Conclusion Our data demonstrated that C-erbB2 gene was overexpressed in salivary gland adenoid cystic carcinoma cell line SACC-83,and it was related to salivary gland adenoid cystic carcinoma genesis.
出处 《口腔医学》 CAS 2010年第8期477-480,共4页 Stomatology
关键词 涎腺腺样囊性癌 C-ERBB2 PTEN 基因治疗 salivary gland adenoid cystic carcinoma C-erbB2 PTEN gene therapy
  • 相关文献

参考文献10

  • 1Nalwoga H, Odida M, Wabinga H. c-erbB-2 oncoprotein over-expression in breast cancer and its relationship to histology and grade in a Ugandan population [ J ]. East Afr Med J, 2006,83 ( 8 ) : 411 -415.
  • 2Homaei-Shandiz F, Ghavam-Nassiri MR, Sharifl N. Evaluation of the relationship between human epidermal growth factor receptor- 2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer [ J ]. Sandi Med J,2006,27 ( 12 ) : 1810 - 1814.
  • 3Couto SS, Cao M, Duarte PC,et al. Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer [ J ]. Differentiation, 2009,77 ( 1 ) : 103 - 111.
  • 4Marry B, Maire V, Gravier E, et al. Frequent PTEN genomie alterations and activated phosphatidylinositol 3-kinase pathway in basallike breast cancer cells [ J]. Breast Cancer Res,2008,10(6) :101 -115.
  • 5Zheng H,Ying H,Yan H,et al. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma [ J ]. Cold Spring Harb Syrup Quant Biol,2008,73 ( 1 ) :427 - 437.
  • 6Kao J,Pollack JR. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes [ J ]. Genes Chromosomes Cancer,2006,45 ( 8 ) :761 - 769.
  • 7Rodriguez OC, Lai EW, Vissapragada S,et al. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1 [ J ]. Am J Pathol, 2009,174 (6) : 2051 - 2060.
  • 8Piekarski JH, Biemat W. Clinical significance of CK5/6 and PTEN protein expression in patients with bilateral breast carcinoma [ J ]. Histopathology ,2006,49 ( 3 ) :248 - 255.
  • 9Faratian D, Goltsov A, Lebedeva G, et al. Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab [ J ]. Cancer Res ,2009, 69(16) :6713 -6720.
  • 10Fujita T, Doihara H, Kawasaki K, et al. PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer [ J ]. Br J Cancer, 2006,94 (2) :247 -252.

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部